Loading the security overview…
Where the tokens are
What Madrigal Pharmaceuticals has filed with the US Securities and Exchange Commission: annual and quarterly reports, current reports of material events, and the forms insiders file when they trade. Each links to the filing’s page on SEC.gov.
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Aug 12, 2026 | 8-K | Current report | On SEC.gov |
| Jul 30, 2026 | 10-Q | Quarterly report | On SEC.gov |
| Jul 30, 2026 | 8-K | Current report | On SEC.gov |
| Jun 17, 2026 | 8-K | Current report | On SEC.gov |
| May 6, 2026 | 10-Q | Quarterly report | On SEC.gov |
| May 6, 2026 | 8-K | Current report | On SEC.gov |
| Apr 28, 2026 | 8-K | Current report | On SEC.gov |
| Feb 19, 2026 | 10-K | Annual report | On SEC.gov |
| Feb 19, 2026 | 8-K | Current report | On SEC.gov |
| Jan 30, 2026 | 8-K | Current report | On SEC.gov |
| Dec 11, 2025 | 8-K | Current report | On SEC.gov |
| Nov 4, 2025 | 10-Q | Quarterly report | On SEC.gov |
| Nov 4, 2025 | 8-K | Current report | On SEC.gov |
| Aug 5, 2025 | 10-Q | Quarterly report | On SEC.gov |
| Aug 5, 2025 | 8-K | Current report | On SEC.gov |
| Jul 30, 2025 | 8-K | Current report | On SEC.gov |
| Jul 22, 2025 | 8-K | Current report | On SEC.gov |
| Jun 20, 2025 | 8-K | Current report | On SEC.gov |
| May 1, 2025 | 10-Q | Quarterly report | On SEC.gov |
| May 1, 2025 | 8-K | Current report | On SEC.gov |
| Apr 17, 2025 | 8-K | Current report | On SEC.gov |
| Mar 11, 2025 | 8-K | Current report | On SEC.gov |
| Feb 26, 2025 | 10-K | Annual report | On SEC.gov |
| Feb 26, 2025 | 8-K | Current report | On SEC.gov |
| Jan 13, 2025 | 8-K | Current report | On SEC.gov |
| Oct 31, 2024 | 10-Q | Quarterly report | On SEC.gov |
| Oct 31, 2024 | 8-K | Current report | On SEC.gov |
| Aug 7, 2024 | 10-Q | Quarterly report | On SEC.gov |
| Aug 7, 2024 | 8-K | Current report | On SEC.gov |
| Jun 27, 2024 | 8-K | Current report | On SEC.gov |
| May 7, 2024 | 10-Q | Quarterly report | On SEC.gov |
| May 7, 2024 | 8-K | Current report | On SEC.gov |
| May 7, 2024 | 8-K | Current report | On SEC.gov |
| Apr 2, 2024 | 8-K | Current report | On SEC.gov |
| Mar 20, 2024 | 8-K | Current report | On SEC.gov |
| Mar 15, 2024 | 8-K | Current report | On SEC.gov |
| Feb 28, 2024 | 10-K | Annual report | On SEC.gov |
| Feb 28, 2024 | 8-K | Current report | On SEC.gov |
| Feb 28, 2024 | 8-K | Current report | On SEC.gov |
| Jan 8, 2024 | 8-K | Current report | On SEC.gov |
| Nov 6, 2023 | 8-K | Current report | On SEC.gov |
| Nov 6, 2023 | 10-Q | Quarterly report | On SEC.gov |
| Oct 2, 2023 | 8-K | Current report | On SEC.gov |
| Sep 25, 2023 | 8-K | Current report | On SEC.gov |
| Sep 14, 2023 | 8-K | Current report | On SEC.gov |
| Sep 13, 2023 | 8-K | Current report | On SEC.gov |
| Sep 13, 2023 | 8-K | Current report | On SEC.gov |
| Aug 8, 2023 | 8-K | Current report | On SEC.gov |
| Aug 8, 2023 | 10-Q | Quarterly report | On SEC.gov |
| Jul 17, 2023 | 8-K | Current report | On SEC.gov |
| Jun 30, 2023 | 8-K | Current report | On SEC.gov |
| Jun 20, 2023 | 8-K | Current report | On SEC.gov |
| Jun 20, 2023 | 8-K | Current report | On SEC.gov |
| May 9, 2023 | 8-K | Current report | On SEC.gov |
| May 9, 2023 | 8-K | Current report | On SEC.gov |
| May 9, 2023 | 10-Q | Quarterly report | On SEC.gov |
| Feb 23, 2023 | 8-K | Current report | On SEC.gov |
| Feb 23, 2023 | 10-K | Annual report | On SEC.gov |
| Feb 9, 2023 | 8-K | Current report | On SEC.gov |
| Jan 10, 2023 | 8-K | Current report | On SEC.gov |
Figures describe Madrigal Pharmaceuticals shares, not any token. As of Sep 28, 2026, from EDGAR, via Massive. Token issuers file nothing here about the company; their own disclosures are on their issuer pages.